180 related articles for article (PubMed ID: 22261338)
21. RETRACTED: Vegetation analysis of Wadi Al-Jufair, a hyper-arid region in Najd, Saudi Arabia.
Alatar A; El-Sheikh MA; Thomas J
Saudi J Biol Sci; 2012 Jan; 19(1):43-54. PubMed ID: 23961161
[TBL] [Abstract][Full Text] [Related]
22. Wild-type RAS: keeping mutant RAS in CHK.
Anastassiadis T; Brown EJ
Cancer Cell; 2014 Feb; 25(2):137-8. PubMed ID: 24525230
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-mediated regulation of KRAS in cancer.
Kim M; Slack FJ
J Hematol Oncol; 2014 Nov; 7():84. PubMed ID: 25433809
[TBL] [Abstract][Full Text] [Related]
24. Retraction notice to "Role of hepatic neuropeptide Y-Y1 receptors in a methionine- cholinedeficient model of non-alcoholic steatohepatitis" [Life Sci. 245 (2020) 117356].
Sun WW; Guan TS; Zhu P; Li HK; Jiang M; Yang P; Li LY; Zhang ZH
Life Sci; 2021 Sep; 281():119210. PubMed ID: 34243946
[TBL] [Abstract][Full Text] [Related]
25. RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.
Yao L; Zhou Y; Sui Z; Zhang Y; Liu Y; Xie H; Gao H; Fan H; Zhang Y; Liu M; Li S; Tang H
EBioMedicine; 2019 Oct; 48():117-129. PubMed ID: 31530503
[TBL] [Abstract][Full Text] [Related]
26. RETRACTED: Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding.
Feng Y; Wang L; Wang T; Li Y; Xun Q; Zhang R; Liu L; Li L; Wang W; Tian Y; Yang L; Zhi X; Zhou B; Chen X; Sun T; Liu Y
Mol Ther; 2021 Jun; 29(6):2151-2166. PubMed ID: 33578038
[TBL] [Abstract][Full Text] [Related]
27. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.
Wang HG; Millan JA; Cox AD; Der CJ; Rapp UR; Beck T; Zha H; Reed JC
J Cell Biol; 1995 May; 129(4):1103-14. PubMed ID: 7744959
[TBL] [Abstract][Full Text] [Related]
28. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
[TBL] [Abstract][Full Text] [Related]
29. RETRACTED: Effects of high-energy electro-pulsing treatment on microstructure, mechanical properties and corrosion behavior of Ti-6Al-4V alloy.
Ye X; Wang L; Tse ZTH; Tang G; Song G
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():851-860. PubMed ID: 25687017
[TBL] [Abstract][Full Text] [Related]
30. Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation.
Su F; Bradley WD; Wang Q; Yang H; Xu L; Higgins B; Kolinsky K; Packman K; Kim MJ; Trunzer K; Lee RJ; Schostack K; Carter J; Albert T; Germer S; Rosinski J; Martin M; Simcox ME; Lestini B; Heimbrook D; Bollag G
Cancer Res; 2012 Feb; 72(4):969-78. PubMed ID: 22205714
[TBL] [Abstract][Full Text] [Related]
31. RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma.
Wang H; Jia R; Zhao T; Li X; Lang M; Lan C; Wang H; Li Z; Zhou B; Wu L; Sun Y; Wang X; Ren H; Hao J
Cancer Lett; 2019 Jul; 453():10-20. PubMed ID: 30922919
[TBL] [Abstract][Full Text] [Related]
32. Retraction notice to "Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia" [Life Sci. 100 (2014) 97-109].
Bhattacharya P; Pandey AK; Paul S; Patnaik R
Life Sci; 2021 Sep; 281():119209. PubMed ID: 34246492
[TBL] [Abstract][Full Text] [Related]
33. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
Levy R; Grafi-Cohen M; Kraiem Z; Kloog Y
Mol Cancer Ther; 2010 Aug; 9(8):2208-19. PubMed ID: 20682656
[TBL] [Abstract][Full Text] [Related]
34. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.
Hu Y; Ou Y; Wu K; Chen Y; Sun W
Tumour Biol; 2012 Dec; 33(6):1863-70. PubMed ID: 23070684
[TBL] [Abstract][Full Text] [Related]
35. RETRACTED: Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice.
Flores MBS; Rocha GZ; Damas-Souza DM; Osório-Costa F; Dias MM; Ropelle ER; Camargo JA; de Carvalho RB; Carvalho HF; Saad MJA; Carvalheira JBC
Gastroenterology; 2012 Sep; 143(3):741-753.e4. PubMed ID: 22677195
[TBL] [Abstract][Full Text] [Related]
36. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells.
Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y
Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells.
Diep CH; Munoz RM; Choudhary A; Von Hoff DD; Han H
Clin Cancer Res; 2011 May; 17(9):2744-56. PubMed ID: 21385921
[TBL] [Abstract][Full Text] [Related]
38. Retraction notice to "Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity " [JNB 24 (2013) 14-24].
Carmona-Ramírez I; Santamaría A; Tobón-Velasco JC; Orozco-Ibarra M; González-Herrera IG; Pedraza-Chaverrí J; Maldonado PD
J Nutr Biochem; 2017 Apr; 42():203. PubMed ID: 28320533
[TBL] [Abstract][Full Text] [Related]
39. CD52 is a molecular target in advanced systemic mastocytosis.
Hoermann G; Blatt K; Greiner G; Putz EM; Berger A; Herrmann H; Cerny-Reiterer S; Gleixner KV; Walz C; Hoetzenecker K; Müllauer L; Reiter A; Sotlar K; Sexl V; Valent P; Mayerhofer M
FASEB J; 2014 Aug; 28(8):3540-51. PubMed ID: 24760752
[TBL] [Abstract][Full Text] [Related]
40. Targets, trials, and travails in pancreas cancer.
Izeradjene K; Hingorani SR
J Natl Compr Canc Netw; 2007 Nov; 5(10):1042-53. PubMed ID: 18053428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
